Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1965 Mar 27;1(5438):813–817.

Measles Vaccination IV. Responses to Two Different Types of Preparations Given as a Fourth Dose of Vaccine*

E Norrby, R Lagercrantz, S Gard
PMCID: PMC2166272  PMID: 14258844

Full text

PDF
817

Images in this article

814Fig. 2
on p.814

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CARTER C. H., CONWAY T. J., CORNFELD D., IEZZONI D. G., KEMPE C. H., MOSCOVICI C., RAUH L. W., VIGNEC A. J., WARREN J. Serologic response of children to in-activated measles vaccine. JAMA. 1962 Mar 17;179:848–853. doi: 10.1001/jama.1962.03050110016003. [DOI] [PubMed] [Google Scholar]
  2. FELDMAN H. A., NOVACK A., WARREN J. Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine. JAMA. 1962 Feb 10;179:391–397. doi: 10.1001/jama.1962.03050060001001. [DOI] [PubMed] [Google Scholar]
  3. FULGINITI V. A., KEMPE C. H. MEASLES EXPOSURE AMONG VACCINE RECIPIENTS. RESPONSE TO MEASLES EXPOSURE AND ANTIBODY PERSISTENCE AMONG RECIPIENTS OF MEASLES VACCINES. Am J Dis Child. 1963 Nov;106:450–461. doi: 10.1001/archpedi.1963.02080050452010. [DOI] [PubMed] [Google Scholar]
  4. FULGINITI V. A., LELAND O. S., KEMPE C. H. Evaluation of measles immunization methos. Am J Dis Child. 1963 Jan;105:5–11. doi: 10.1001/archpedi.1963.02080040007002. [DOI] [PubMed] [Google Scholar]
  5. GITLIN D., JANEWAY C. A. The gamma globulins. Adv Pediatr. 1957;9:65–136. [PubMed] [Google Scholar]
  6. MARTIN C. M., MANFREDONIA S. J., WEBB N. C., Jr, MARKHAM F. S., RUEGSEGGER J. M. CONTROLLED TRIAL OF LIVE MEASLES VACCINE. EFFECTS OF AGE, HISTORY OF MEASLES IN SIBLINGS, PREVACCINE ANTIBODY, AND HUMAN GAMMA-GLOBULIN ON SYMPTOMATIC AND IMMUNE RESPONSES. Am J Dis Child. 1963 Sep;106:267–279. [PubMed] [Google Scholar]
  7. MEDOFF H. S., HUNT A. R., KARPINSKI F. E., Jr, SALITSKY S., WHEELER J. E. EPIDEMIOLOGIC STUDY OF INACTIVATED MEASLES VACCINE. JAMA. 1964 Sep 7;189:723–728. doi: 10.1001/jama.1964.03070100017003. [DOI] [PubMed] [Google Scholar]
  8. NORRBY E., CARLSTROEM G., LAGERCRANTZ R., GARD S. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE. Acta Paediatr. 1964 Nov;53:533–540. doi: 10.1111/j.1651-2227.1964.tb07265.x. [DOI] [PubMed] [Google Scholar]
  9. NORRBY E., LAGERCRANTZ R., GARD S., CARLSTROEM G. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE. Arch Gesamte Virusforsch. 1963 Aug 26;13:548–558. [PubMed] [Google Scholar]
  10. STOKES J., Jr, HILLEMAN M. R., WEIBEL R. E., BUYNAK E. B., HALENDA R. Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med. 1962 Aug 2;267:222–224. doi: 10.1056/NEJM196208022670503. [DOI] [PubMed] [Google Scholar]
  11. STOKES J., Jr, REILLY C. M., BUYNAK E. B., HILLEMAN M. R. Immunologic studies of measles. Am J Hyg. 1961 Nov;74:293–303. doi: 10.1093/oxfordjournals.aje.a120220. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES